Pediatric use of insulin pump technology: A retrospective study of adverse events in children ages 1-12 years

Journal of Diabetes Science and Technology

Volumn 6, Issue 5, 2012, Pages 1053-1059

  Cope, Judith U ^a   Samuels Reid, Joy H ^b   Morrison, Audrey E ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b CENTER FOR DEVICES AND RADIOLOGICAL HEALTH   (United States)

Author keywords

Adverse event reports; Children; Device related problems; Diabetes; Diabetic ketoacidosis; Hospitalization; Hyperglycemia; Hypoglycemia; Insulin pump; Malfunction; Manufacturer evaluation; Pediatric; Postmarket; Use error

Indexed keywords

ABSCESS; AGE; ARTICLE; CHILD; DEATH; DIABETIC KETOACIDOSIS; DIABETIC PATIENT; EMERGENCY WARD; EQUIPMENT FAILURE; EVALUATION STUDY; FOOD AND DRUG ADMINISTRATION; GENDER; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN PUMP; MEDICAL DEVICE COMPLICATION; OUTCOME ASSESSMENT; PARAMEDICAL PERSONNEL; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; DRUG TOXICITY; EVALUATION; FEMALE; INFANT; INSULIN INFUSION; MALE; METHODOLOGY; PEDIATRICS; STATISTICS; UTILIZATION REVIEW;

ANTIDIABETIC AGENT; INSULIN;

AGE FACTORS; CHILD; CHILD, PRESCHOOL; DIABETIC KETOACIDOSIS; DRUG TOXICITY; FEMALE; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFANT; INSULIN; INSULIN INFUSION SYSTEMS; MALE; PEDIATRICS; RETROSPECTIVE STUDIES;

EID: 84875814608     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681200600509     Document Type: Article

References (18)

1. Cope JU, Morrison AE, Samuels-Reid J. Adolescent use of insulin and patient-controlled analgesia pump technology: a 10-year Food and Drug Administration retrospective study of adverse events. Pediatrics. 2008;121(5):e1133-8.
2. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Beck RW, Buckingham B, Miller K, Wolpert H, Xing D, Block JM, Chase HP, Hirsch I, Kollman C, Laffel L, Lawrence JM, Milaszewski K, Ruedy KJ, Tamborlane WV. Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care. 2009;32(11):1947-53. Epub 2009 Aug 12.
3. How to Report a Problem (Medical Devices). U.S. Food and Drug Administration. http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default. htm. Accessed February 29, 2012.
4. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. J Pediatr. 1994;125(2):177-88.
5. Fatourechi MM, Kudva YC, Murad MH, Elamin MB, Tabini CC, Montori VM. Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. J Clin Endocrinol Metab. 2009;94(3):729-40. Epub 2008 Dec 16.
6. Churchill JN, Ruppe RL, Smaldone A. Use of continuous insulin infusion pumps in young children with type 1 diabetes: a systematic review. J Pediatr Health Care. 2009;23(3):173-9. Epub 2008 Aug 23.
7. Buckingham B, Caswell K, Wilson DM. Real-time continuous glucose monitoring. Curr Opin Endocrinol Diabetes Obes. 2007;14(4):288-95. (Pubitemid 47067113)
8. De Vries L, Grushka Y, Lebenthal Y, Shalitin S, Phillip M. Factors associated with increased risk of insulin pump discontinuation in pediatric patients with type 1 diabetes. Pediatr Diabetes. 2011;12(5):506-12. doi: 10.1111/j.1399-5448.2010.00701.x. Epub 2010 Aug 15.
9. Shalitin S, Phillip M. The use of insulin pump therapy in the pediatric age group. Horm Res. 2008;70(1):14-21. Epub 2008 May 21.
10. Sovik O, Thordarson H. Dead-in-bed syndrome in young diabetic patients. Diabetes Care. 1999;22 Suppl 2:B40-2. (Pubitemid 29107147)
11. Zhang Y, Jones PL, Klonoff DC. Second insulin pump safety meeting: summary report. J Diabetes Sci Technol. 2010;4(2):488-93.
12. Zhang Y, Jones PL, Jetley R. A hazard analysis for a generic insulin infusion pump. J Diabetes Sci Technol. 2010;4(2):263-83.
13. Fuld K, Conrad B, Buckingham B, Wilson DM. Insulin pumps in young children. Diabetes Technol Ther. 2010;12 Suppl 1:S67-71.
14. Maahs DM, Horton LA, Chase HP. The use of insulin pumps in youth with type 1 diabetes. Diabetes Technol Ther. 2010;12 Suppl 1:S59-65.
15. Scrimgeour L, Cobry E, McFann K, Burdick P, Weimer C, Slover R, Chase HP. Improved glycemic control after long-term insulin pump use in pediatric patients with type 1 diabetes. Diabetes Technol Ther. 2007;9(5):421-8. (Pubitemid 47585352)
16. Wood JR, Moreland EC, Volkening LK, Svoren BM, Butler DA, Laffel LM. Durability of insulin pump use in pediatric patients with type 1 diabetes. Diabetes Care. 2006;29(11):2355-60. (Pubitemid 44912235)
17. MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The U.S. Food and Drug Administration. http://www.fda.gov/Safety/MedWatch/ default.htm. Accessed February 29, 2012.
18. Draft Guidance for Industry and FDA Staff - Total Product Life Cycle: Infusion Pump - Premarket Notification [510(k)] Submissions. http://www.fda.gov/medicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ ucm206153.htm. Accessed August 1, 2012.